CoChat

Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade

Karakus, Kagan E., Akturk, Halis K., Alonso, G. Todd, Snell-Bergeon, Janet K., Shah, Viral N. · 2023 · Diabetes Care

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To evaluate change in mean clinic HbA1c from 2014 to 2021 with diabetes technology use in adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: In this single-center study, we analyzed diabetes technology use and mean clinic HbA1c among unique adults (age ≥18 years) with type 1 diabetes (last visit of the year per patient) between 1 January 2014 and 31 December 2021 from the electronic medical record. Diabetes technology use was defined as the use of continuous glucose monitors (CGMs) without an automated insulin delivery (AID) system or an AID system. Diabetes technology use and HbA1c over time were analyzed using mixed models adjusted for age, sex, and visit year. RESULTS: A total of 15,903 clinic visits over 8 years (mean 1,988 patients per year, 4,174 unique patients, 52.7% female, 80.0% Non-Hispanic White) showed significant increases in CGM and AID use (P < 0.001 for both), resulting in an increase of diabetes technology use from 26.9% in 2014 to 82.7% in 2021. These increases were associated with a lower mean clinic HbA1c (7.7–7.5%, P < 0.001) and a higher percentage of adults achieving an HbA1c <7.0% (32.3–41.7%, P < 0.001) from 2014 to 2021. The HbA1c difference between technology users and nonusers increased over time from 0.36% (95% CI 0.26–0.47%, P < 0.001) in 2014 to 0.93% (95% CI 0.80–1.06%, P < 0.001) in 2021. CONCLUSIONS: Adopting diabetes technology in adults with type 1 diabetes decreased HbA1c and increased the number of people achieving an HbA1c <7.0%, supporting the current international recommendation to offer AID systems to most individuals with type 1 diabetes.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc23-0495

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

See all 52

Metadata

Authors
Karakus, K. E., Akturk, H. K., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N.
Affiliations
  • Koç University (TR)
  • 1Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO
  • University of Colorado Anschutz (US)
Corresponding author
Shah, Viral N.
Venue
Diabetes Care
Published
2023-07-17
Volume
46
Issue
9
Pages
1646-1651
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4384560404
Cited by
52
References
28
Citations by year
2026: 9 · 2025: 19 · 2024: 24
FWCI
10.69
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 1 diabetes, diabetes technology, continuous glucose monitoring, artificial pancreas, glycemic control, HbA1c, adults, technology adoption trends, glycemic targets
MeSH terms
Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Male, Blood Glucose Self-Monitoring, Pancreas, Artificial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade. https://app.cochat.ai/papers/10.2337/dc23-0495
The paper
Karakus, K. E., Akturk, H. K., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2023). Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade. Diabetes Care. https://doi.org/10.2337/dc23-0495

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.